Skip to main content
Watch Insiders
Market intelligence
MBXHealthcare

MBX Biosciences Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
May 8, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 8, 2026Salomon AzoulayChief Medical OfficerSale70,003$38.36$2,685,518
May 6, 2026Salomon AzoulayChief Medical OfficerSale231$29.54$6,824
May 6, 2026P. Kent HawrylukPresident & CEOSale607$29.54$17,931